Tag: FDA orphan designation

Orphan Drug Exclusivity: How Rare-Disease Medicines Get Market Protection

Orphan Drug Exclusivity: How Rare-Disease Medicines Get Market Protection

Orphan drug exclusivity gives pharmaceutical companies seven years of market protection for rare-disease treatments, driving innovation where profits were once impossible. Here's how it works, who benefits, and why it's under scrutiny.

Popular Posts

Tags

drug interactions medication safety generic drugs online pharmacy Hatch-Waxman Act side effects authorized generics medication errors FDA regulations patient education therapeutic equivalence prior authorization generic substitution patient safety medication interactions Online Pharmacy Tadalafil wellness sexual health mental health

Categories